MARKETING-BASED MEDICINE

‘Internal documents from the pharmaceutical industry suggest that the publicly available evidence base may not accurately represent the underlying data regarding its products. The industry and its associated medical communication firms state that publications in the medical literature primarily serve marketing interests. Suppression and spinning of negative data and ghostwriting [see Chapter 10, p124–5] have emerged as tools to help manage medical journal publications to best suit product sales, while disease mongering and market segmentation of physicians are also used to efficiently maximize profits. We propose that while evidence-based medicine is a noble ideal, marketing-based medicine is the current reality.’

Spielmans GI, Parry PI. From Evidence-based Medicine to Marketing-based Medicine: Evidence from Internal Industry Documents. Journal of Bioethical Inquiry 2010;7(1):13–29. Available online: http://tinyurl.com/Spielmans.

From: Chapter 8, Assessing all the relevant, reliable evidence

Cover of Testing Treatments
Testing Treatments: Better Research for Better Healthcare. 2nd edition.
Evans I, Thornton H, Chalmers I, et al.
London: Pinter & Martin; 2011.
Copyright © 2011 Imogen Evans, Hazel Thornton, Iain Chalmers and Paul Glasziou.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.